Atypical Presentation of Coxiella burnetii Endocarditis: Diagnostic Considerations and the Importance of Keeping a Broad Differential (2024)

  • Journal List
  • Cureus
  • v.16(7); 2024 Jul
  • PMC11292982

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Atypical Presentation of Coxiella burnetii Endocarditis: Diagnostic Considerations and the Importance of Keeping a Broad Differential (1)

Link to Publisher's site

Cureus. 2024 Jul; 16(7): e63659.

Published online 2024 Jul 2. doi:10.7759/cureus.63659

PMCID: PMC11292982

PMID: 39092334

Monitoring Editor: Alexander Muacevic and John R Adler

Michael Fragner,Atypical Presentation of Coxiella burnetii Endocarditis: Diagnostic Considerations and the Importance of Keeping a Broad Differential (2)1 Sudarshan S Srivats,2 Kevin Pink,3 and Hassan Abuhashish1

Author information Article notes Copyright and License information PMC Disclaimer

Abstract

Coxiella burnetii is a gram-negative bacterium associated with serious complications such as infective endocarditis. Early diagnosis and treatment can be difficult due to its nonspecific presentation and risk factors that include contact with farm animals or their byproducts. Here, we present an atypical presentation of infective endocarditis caused by Coxiella burnetii, where the patient had no risk factors, negative Dukecriteria, and negative preliminary workup.

Keywords: aortic valve infective endocarditis, prosthetic valve infective endocarditis, q-fever, culture negative infective endocarditis, coxiella burnetti

Introduction

Infective endocarditis (IE) is characterized by bacterial colonization on the endocardial surfaces of cardiac valves or, in some cases, intracardiac devices. Common organisms in IE include Staphylococcus and Streptococcus; however, Coxiella burnetii (C. burnetii) can be the culprit on rare occasions with an incidence of 1 in 1,000,000 [1].The bacterium responsible for "Q fever," C. burnetii, is a gram-negative organism primarily transmitted to humans through contact with infected animals such as cattle, sheep, goats, or even dogs in some instances [2,3]. Symptoms are nonspecific and include fever, fatigue, night sweats, weight loss, and heart murmurs [4].

Although early recognition and treatment are crucial to avoid potential complications, the diagnosis of C. burnetii IE can be challenging due to its nonspecific symptoms and slow-growing nature, leading to treatment delays and poor prognosis [5]. Clinicians should consider C. burnetii IE in patients presenting with nonspecific symptoms when they have had previous exposure to farm animals or their byproducts. It is vital to recognize the importance of considering Q fever in patients with culture-negative endocarditis and prosthetic heart valves. This reportwas previously presented as a meeting abstract at the 2024 ACC Annual Scientific Session in April 2024 and is greatly expanded on, demonstratinga rare presentation of IE caused by C. burnetii, which was identified early and successfully treated.

Case presentation

A 58-year-old Dominican male, with a history of hypertension, hyperlipidemia, non-insulin-dependent diabetes, heart failure with preserved ejection fraction due to ischemic cardiomyopathy, implantable cardioverter defibrillator (ICD), and triple vessel disease requiring coronary artery bypass graft(CABG) using a saphenous vein graft to the left anterior descending artery, presented for intermittent chills and rigors over the past several months. He also has a history of aortic stenosis requiring a bioprosthetic aortic valve replacement (AVR). This was complicated by prosthetic valve endocarditis (PVE) requiring sternotomy and mechanical AVR with an ascending aorta conduit.

Three weeks prior to this admission, he presented with similar symptoms with additionalpleuritic chest pain. Evaluation at that time was unremarkable, and he was discharged home without antibiotics or new medications. Of note, his last visit to the Dominican Republic was more than 10 years ago where he worked as a police officer. Since being in Brooklyn, he has worked in construction. He denied any exposure to animals besides a dog for a brief period over 10 years ago. On admission, he was hemodynamically stable and afebrile. A physical exam demonstrated a well-appearing, obese male with evidence of a systolic murmur at the second right intercostal space. There was no evidence of lower extremity edema, respiratory distress, or volume overload.

Laboratory values on admission were notable for a white blood cell count of 10,220/microliter, erythrocyte sedimentation rate of 113 mm/hr, C-reactive protein of 45.2 mg/L, pro-brain natriuretic peptide (pro-BNP) of 423 pg/mL, and two negative high sensitivity troponin values. The electrocardiogram on admission showed sinus rhythm with a first-degree AV block and left-axis deviation.Given the concern for the recurrence of infective endocarditis, the patient was admitted to the cardiology floor and started on intravenous vancomycin and ceftriaxone empirically for broad-spectrum antibioticcoverage. A transesophageal echocardiogram showed an ejection fraction of 60% and a large, irregular, mobile vegetation on the ventricular aspect of the posterior aortic valve ring extending to the aortomitral continuity. Thesefindings were consistent with paravalvular abscess (Figure ​(Figure11).

Figure 1

Open in a separate window

Transesophageal echocardiogram mid-esophageal view

Arrow indicating aortic root thickening andirregular vegetation on the ventricular aspect of the posterior aortic valve ring extending to the aortomitral continuity, consistent with a para-valvular abscess.

Due to the patient’s subacute presentation, there was concern for a possible underlying immunocompromised state, such as human immunodeficiency virus, which was ruled out. His history and risk factor of a mechanical valve raised suspicion for infective endocarditis.

Cardiac, chest, and abdominal CT angiography were performed, which revealed diffuse thickening of the aortic root. Serial blood cultures collected prior to antibiotics were performed and remained negative throughout the hospital stay; however, serum serology returned positive with elevated immunoglobulin G (IgG) titers for Coxiella burnetii (1:131072). These findings were concerning for Coxiella burnetii IE, and his antibiotics were switched to doxycycline and he was started on hydroxychloroquine. During the patient’s hospital stay, telemetry noted frequent bouts of nonsustained ventricular tachycardia and prolongation of the PR interval on daily EKGs (300-340 milliseconds) concerning for involvement of the conduction system. Follow-up fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT)imaging showed irregular thickening and intense radioactive tracer avidityof the mechanical aortic valve and root (Figure ​(Figure22).

Figure 2

Open in a separate window

Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT)

Irregular thickening and intense FDG avidity of the mechanical aortic valve and aortic root, suspicious for infectious/inflammatory etiology

The patient was evaluated for extraction of his ICD and re-operative AVR conduit. Cardiac catheterization was completed showing a patent graft to the left anterior descending artery and normal left and right heart pressures. The patient subsequently underwent ICD lead extraction after completion of three weeks of intravenous antibiotics. Soon after ICD lead extraction, the patient had a re-operative AVR conduit and root replacement without complication.

Discussion

Coxiella burnetii (Q fever) is a rare cause of IE. The etiology includes contact of skin or mucous membranes with infected animal tissue or fluid, inhalation of infected aerosolized particles, or consumption of unpasteurized dairy products; the latter being the most common means of transmission [6]. Acute Q fever typically presents as fever, headache, and cough, allowingthe diagnosis to be easily missed, as it masquerades as a typical viralillness. If not treated, acute Q fever can progress to chronic Q fever months to years after initial infection [4]. In our case, the peculiarity of the patient is that he never had notable risk factors that would make one suspect Q fever. However, given no obvious source of infection with negative blood cultures, Coxiella burnetii was tested.An uncommon manifestation of chronic Q fever is IE, which is seen in immunosuppressed patients or those with prosthetic heart valves or vascular abnormalities [7].Those with prosthetic valves are at higher risk compared to those with native valvular anomalies. More often the mitral and aortic valves are affected. Coxiella burnetii endocarditis should be suspected if there are clinical and echocardiographic findings suggesting endocarditis, and if blood cultures are negative within 72-96 hours [8].

Diagnosis is made via serological testing using indirect immunofluorescence assay (IFA) that detects antibodies in serum, both IgM and IgG [8]. There is an antigenic phase I and antigenic phase II to which antibody responses are developed. During an acute infection with Q fever, Coxiella burnetii phase II antigen predominates, while in chronic infection, the phase I antigen is higher and more often IgG. IgM antibodies will rise with IgG antibodies; however, IgM will remain elevated for longer periods of time and have an increased rate of cross-reactivity with other speciessuch as Bartonella and Legionella. Thus, IgM titers have a lower specificity in diagnosis than IgG, but both IgM and IgG titers should be tested to obtain serologic diagnosis. IgG titers are used to detect chronic Q fever. UsingDuke criteria for IE, an IgG antibody titer >1:800 is deemed amajor criterion. If this is seen, the performance of a transthoracic echocardiogram (TTE) is indicated for further evaluation[9,10]. Additionally, polymerase chain reaction (PCR) can be used for diagnosis but is more sensitive in the first two weeks of illness (acute phase) and within 24-48 hours of antibiotic administration. Thus, a negative PCR test does not rule out the diagnosis andserological testing should be performed[8].

Imaging has emerged as an innovative tool in the diagnosis ofCoxiella burnetii infection, especially for infective endocarditis. Specifically, FDG-PET/CT has become increasingly useful in localizing foci of infectiondue to the ability of inflammatory cells to uptake a significant amount of FDG. This is especially important in Q fever due to its broad predilectionfor affecting multiple organs at once [11]. In Eldin et al.'s retrospective study of 167 patients who were diagnosed with C. burnetii infection and had undergone FDG-PET/CT, 21 patientswere suggested to have endocarditis. Interestingly, in this subgroup prior to the study, 13 patientswere determined to possibly have IE, 5 were not suspected to have IE at all, and only 3 had definite IE. Six cases were on native valves, 14 were on prosthetic valves, and 1 was on a pacemaker [11]. By retrospectively analyzing 25 patients with confirmed IE (18 prosthetic valves, 7 native valves), Ricciardi et al. showed that although TTE had a higher sensitivity for the detection of IE as compared toFDG-PET/CT overall (80% vs 55%),FDG-PET/CT was better at detectingPVE compared to TTE. In this study, 16/18 PVE cases were detected usingFDG-PET/CT. By examining the cases that underwent transesophageal echocardiography, sensitivity for detecting PVE was greatest utilizingFDG-PET/CT (85%) as compared to echocardiography (69%) and Duke criteria (77%) [12].Given the propensity for C. burnetii IE to present clandestinely, and often without typical features of endocarditis such as vegetations,FDG-PET/CT has emerged as a resourceful option to enhancediagnosis. This is especially true for PVE.

The mainstay of treatment of chronic Q fever with endocarditis is with doxycycline, 100 mg every 12 hours, and hydroxychloroquine, 200 mg every 8 hours, for a minimum of 18 months or up to 24 months in patients with prosthetic valves [13]. Duration of treatment is based on serologic response via IgG titers and with clinical improvement. Frequent monitoring of serology is required during treatment due to the possibility of a relapse of the disease if treatment is stopped too soon [14]. In a case series described by Sanchez-Recalde et al., 20 patients with Coxiella burnetii IE were studied, of which 14 patients had prosthetic heart valves, 6 had native heart valves, and 15 of the 20 ultimately required valve replacement [15]. Additionally, it is imperative to note the mortality rate is higher in patients with Q fever IE as compared to patients with Q fever but without complications. In a study by van Roeden et al. examining a cohort of patients with chronic Q fever, the mortality rate was demonstrated to be an extraordinary38% with a median follow-up of 3.7 years, further highlighting the severity of Q fever IE [16].

Conclusions

IEis associatedwith a high mortality rate, especially in patients with PVE complicated by paravalvular invasion. In suspected endocarditis, it is imperative to keep a broad differential diagnosis. Judicious and timely diagnosis of IE using the modified Duke criteria allows for prompt identification of the suspected microorganism and initiation of appropriate antibiotics. It is vital to understand the potential complications associated with Coxiella burnetii IE, such as paravalvular abscess formation and involvement of the conduction system, and the need for timely surgical intervention in severe cases. Clinicians should also understand the high mortality rate in Q fever IE compared to Q fever without complicationsand the importanceof regular follow-up. Coxiella burnetii should be strongly considered as part of the differential diagnosis when suspecting IE, especially in patients with risk factors presenting with aninsidious course.

Disclosures

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Author Contributions

Concept and design: Michael Fragner, Hassan Abuhashish

Acquisition, analysis, or interpretation of data: Michael Fragner, Hassan Abuhashish, Kevin Pink, Sudarshan S. Srivats

Drafting of the manuscript: Michael Fragner, Kevin Pink, Sudarshan S. Srivats

Critical review of the manuscript for important intellectual content: Michael Fragner, Hassan Abuhashish, Kevin Pink, Sudarshan S. Srivats

References

1. Q fever. Maurin M, Raoult D. Clin Microbiol Rev. 1999;12:518–553. [PMC free article] [PubMed] [Google Scholar]

2. Epidemiological survey on the route of Coxiella burnetii infection in an animal hospital. Komiya T, Sadamasu K, Toriniwa H, et al. J Infect Chemother. 2003;9:151–155. [PubMed] [Google Scholar]

3. A dog-related outbreak of Q fever. Buhariwalla F, Cann B, Marrie TJ. Clin Infect Dis. 1996;23:753–755. [PubMed] [Google Scholar]

4. Neupane K, Kaswan D. Treasure Island (FL): StatPearls [Internet]; 2024. Coxiella burnetii Infection. [PubMed] [Google Scholar]

5. Q Fever: a troubling disease and a challenging diagnosis. Miller HK, Priestley RA, Kersh GJ. Clin Microbiol Newsl. 2021;43:109–118. [PMC free article] [PubMed] [Google Scholar]

6. Review of clinical and laboratory features of human brucellosis. Mantur BG, Amarnath SK, Shinde RS. Indian J Med Microbiol. 2007;25:188–202. [PubMed] [Google Scholar]

7. Risks factors and prevention of Q fever endocarditis. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Clin Infect Dis. 2001;33:312–316. [PubMed] [Google Scholar]

8. Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. Anderson A, Bijlmer H, Fournier PE, et al. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6203a1.htm MMWR Recomm Rep. 2013;62:1–23. [PubMed] [Google Scholar]

9. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Li JS, Sexton DJ, Mick N, et al. Clin Infect Dis. 2000;30:633–638. [PubMed] [Google Scholar]

10. Q fever serology: cutoff determination for microimmunofluorescence. Dupont HT, Thirion X, Raoult D. Clin Diagn Lab Immunol. 1994;1:189–196. [PMC free article] [PubMed] [Google Scholar]

11. 18F-FDG PET/CT as a central tool in the shift from chronic Q fever to Coxiella burnetii persistent focalized infection: a consecutive case series. Eldin C, Melenotte C, Million M, et al. Medicine (Baltimore) 2016;95:0. [PMC free article] [PubMed] [Google Scholar]

12. 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. Ricciardi A, Sordillo P, Ceccarelli L, et al. Int J Infect Dis. 2014;28:219–224. [PubMed] [Google Scholar]

13. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Million M, Thuny F, Richet H, et al. Lancet Infect Dis. 2010;10:527–535. [PubMed] [Google Scholar]

14. Treatment of Q fever endocarditis. Comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Raoult D, Houpikian P, Tissot Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Arch Intern Med. 1999;159:167–173. [PubMed] [Google Scholar]

15. Coxiella burnetii endocarditis: long-term clinical course in 20 patients [Article in Spanish] Sánchez-Recalde A, Maté I, López E, et al. Rev Esp Cardiol. 2000;53:940–946. [PubMed] [Google Scholar]

16. Chronic Q fever-related complications and mortality: data from a nationwide cohort. van Roeden SE, Wever PC, Kampschreur LM, et al. Clin Microbiol Infect. 2019;25:1390–1398. [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

Atypical Presentation of Coxiella burnetii Endocarditis: Diagnostic Considerations and the Importance of Keeping a Broad Differential (2024)

FAQs

What is the diagnostic test for Coxiella burnetii? ›

Diagnosis of chronic Q fever

Whole blood, serum or tissue biopsies may be tested by PCR for C. burnetii. PCR of whole blood has low sensitivity in patients with chronic Q fever endocarditis, so serum antibody titers should also be tested.

How do you treat Coxiella burnetii infective endocarditis? ›

The most current recommendation for endocarditis is combination treatment with doxycycline and hydroxychloroquine for at least 18 months to eradicate any remaining C burnetii and prevent relapses.

What is the medical importance of Coxiella burnetii? ›

Coxiella burnetii is the causative agent of Q fever, which is a zoonotic disease. Q fever can present as a febrile illness, pneumonia, or hepatitis.

What is a differential diagnosis for Q fever? ›

Differential Diagnosis: Viral pneumonia, psittacosis, "atypical" pneumonia, pulmonary mycotic disease, endocarditis, hepatitis, adenovirus infection. c. Diagnosis: A four-fold rise in serum antibody between acute and convalescent sera. Serologic testing in combination with PCR is recommended.

What is Coxiella burnetii caused by? ›

Q fever is a disease caused by the bacteria Coxiella burnetii. These bacteria naturally infect some animals, such as goats, sheep, and cows. These bacteria are found in the birth products (i.e. placenta, amniotic fluid), urine, poop, and milk of infected animals.

Is Coxiella burnetii contagious? ›

C. burnetti is easily spread by aerosols; airborne particles can travel a half-mile or more. Humans most often become infected by breathing in the bacteria through airborne barnyard dust contaminated by dried birth fluids, placental material, or waste of infected herd animals.

What are the complications of Coxiella burnetii? ›

The presence of anticardiolipin antibodies during acute Q fever has been associated with several complications, including hepatitis, cholecystitis, endocarditis, thrombosis, hemophagocytic syndrome, meningitis, and progression to persistent endocarditis.

Can bacterial endocarditis be treated? ›

Endocarditis, most often from a bacterial infection, inflames the lining of your heart valves and chambers. Treatment includes several weeks of antibiotics or other medicine and sometimes surgery. With quick, aggressive treatment, many people survive.

Is Coxiella burnetii a parasite? ›

Coxiella burnetti, the etiologic agent of Q fever, is an oligate intracellular parasite of eukaryotes. Unlike the majority of successful bacterial parasites, which escape the bactericidal environment of the phagolysosome by various means, C. burnetii multiplies only in the phagolysosome.

How do most humans acquire Coxiella? ›

Humans are typically exposed to Coxiella through close contact with infected animals or their birth products (e.g., placentas, fetuses, amniotic fluid), urine, feces, or milk. People can also become infected by breathing in contaminated dust or aerosols.

Is Coxiella burnetii positive or negative? ›

Coxiella burnetii is a small Gram-negative intracellular bacterium and is the causative agent of Q fever, which is a zoonotic disease with a worldwide distribution.

What is the target cell for Coxiella burnetii? ›

Coxiella burnetii is a highly infectious pathogen that causes Q fever, a leading cause of culture-negative endocarditis. Coxiella first targets alveolar macrophages and forms a phagolysosome-like compartment called the Coxiella-Containing Vacuole (CCV).

How do you treat Coxiella burnetii endocarditis? ›

Tetracycline, used either alone or in conjunction with valve replacement, has often been effective in controlling Q fever infections. The antibiotic drug regimen currently used is tetracycline, 2 g/d for several months then 1 g/d for at least 1 year. Surgery is undertaken when heart failure occurs.

How do you diagnose Coxiella burnetii? ›

The diagnosis of Q fever relies mainly upon serology, the most commonly used method being the immunofluorescence assay. Serological testing for Q fever should always be done for a patient with a febrile illness and negative blood cultures.

What are the symptoms of Q fever Coxiella burnetii? ›

Signs and symptoms of Q fever may include:
  • Fever.
  • Chills or sweats.
  • Fatigue (tiredness)
  • Headache.
  • Muscle aches.
  • Nausea, vomiting, or diarrhea.
  • Chest pain.
  • Weight loss.
May 15, 2024

What is the diagnosis of Q fever? ›

Diagnosis of Q Fever

Contact with animals or animal products is an important clue. IFA of infected tissue is the diagnostic method of choice; alternatively, enzyme-linked immunosorbent assay (ELISA) may be done. Acute and convalescent serum specimens (typically complement fixation) may be used.

What is the gold standard for diagnosis of Q fever? ›

There are three commercially available serological assays for the diagnosis of Q fever. Of these, the gold standard is the indirect immunofluorescence antibody assay (IFA). To perform the IFA, phase I and phase II antigens are coated onto individual wells of a microscope slide.

What is molecular detection of Coxiella burnetii? ›

After the DNA was extracted from each tick sample; Nested-PCR method was used to identify the presence of C. burnetii using IS1111 transposon gene and isocitrate dehydrogenase icd gene. In addition, phylogenetic analysis and tree diagram were constructed based on IS1111 and icd genes.

How does the Q fever test work? ›

People must be tested to make sure they are not already immune to Q fever before they are vaccinated with Q-Vax, otherwise, they can have a severe reaction to the vaccine. Testing involves a skin test and a blood test. Results of the skin test are ready seven days later.

Top Articles
Latest Posts
Article information

Author: Jamar Nader

Last Updated:

Views: 6172

Rating: 4.4 / 5 (55 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Jamar Nader

Birthday: 1995-02-28

Address: Apt. 536 6162 Reichel Greens, Port Zackaryside, CT 22682-9804

Phone: +9958384818317

Job: IT Representative

Hobby: Scrapbooking, Hiking, Hunting, Kite flying, Blacksmithing, Video gaming, Foraging

Introduction: My name is Jamar Nader, I am a fine, shiny, colorful, bright, nice, perfect, curious person who loves writing and wants to share my knowledge and understanding with you.